Yes Dr. Missling had not yet met with the FDA, although during his last call he did say he wanted to start with the EMA first so by that it's no surprise. By the tone of his reference to Biogen stopping its Aduhelm program, he said something to the matter of now being a good time. They are now preparing is my take.